Risultati di ricerca
1 giu 2023 · Our guidelines are based on the best available evidence. Our recommendations are put together by experts, people using services, carers and the public. Each guideline is developed according to a process that starts from the topic being chosen and extends to any future guideline updates.
15 nov 2023 · Mental health guidelines. In development GID-HUB10005. Register as a stakeholder. Project information. This webpage covers all NICE’s guidelines on mental health. The table presents the guidelines alphabetically. Updates planned or in progress and areas we’re actively monitoring are listed for each guideline, and there are links to the ...
Guidance programme (1 selected) Guidance programme Antimicrobial prescribing guidelines (20) Cancer service guidelines (8) Clinical guidelines (223) COVID-19 rapid guidelines (3) Diagnostics guidance (47) Health technology evaluations (18) Highly specialised technologies guidance (27) Interventional procedures guidance (601) Medical technologies guidance (67) Medicines practice guidelines (5 ...
23 mar 2021 · NICE has also produced COVID-19 rapid guidelines on managing long-term effects of COVID-19 (‘long COVID’) and haematopoietic stem cell transplantation. In May 2024 , we updated the guidance on remdesivir and added a new recommendation on tixagevimab plus cilgavimab in line with NICE’s technology appraisal guidance on remdesivir and tixagevimab plus cilgavimab for treating COVID-19 .
29 giu 2022 · Making decisions using NICE guidelines explains how we use words to show the strength (or certainty) of our recommendations, and has information about prescribing medicines (including off-label use), professional guidelines, standards and laws (including on consent and mental capacity), and safeguarding.
NICE clinical guidelines: provide recommendations for the treatment and care of people by health professionals. are used to develop standards to assess the clinical practice of individual health professionals. are used in the education and training of health professionals. help patients to make informed decisions.
1.9.2. Offer maternal corticosteroids to women between 24+0 and 33+6 weeks of pregnancy who are in suspected, diagnosed or established preterm labour, are having a planned preterm birth or have P‑PROM. [2015, amended 2019] 1.9.3. Consider maternal corticosteroids for women between 34+0 and 35+6 weeks of pregnancy who are in suspected ...
